Newswise COVID Experts

Filters close
Released: 26-Apr-2024 12:05 PM EDT
Texas Biomed Researching Vaccines and Treatments for Highly Pathogenic Avian Influenza
Texas Biomedical Research Institute

Researchers at Texas Biomedical Research Institute (Texas Biomed) are studying potential vaccines, antivirals and antibodies against highly pathogenic avian influenza, including H5N1 strains that closely mirror the one recently detected in cows, chickens and one person in Texas.

Released: 26-Apr-2024 12:00 PM EDT
Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19
World Journal of Stem Cells

Coronavirus disease 2019 (COVID-19) is an acute respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infection typically presents with fever and respiratory symptoms, which can progress to

Newswise: Nanopore-optofluidic-chip-242x300.jpg.webp
Released: 26-Apr-2024 11:05 AM EDT
New Diagnostic Tool Achieves Accuracy of Pcr Tests with Faster and Simpler Nanopore System
Texas Biomedical Research Institute

Researchers at Texas Biomed collaborate with teams at UC Santa Cruz and Brigham Young University to verify the new diagnostic system, which combines optofluidics and nanopores, accurately tests for COVID-19 and Zika virus.

25-Apr-2024 12:05 PM EDT
Undocumented Latinx patients got COVID-19 vaccine at same rate as U.S. citizens
University of California, Los Angeles (UCLA), Health Sciences

For undocumented Latinx patients who sought care in the emergency room during the pandemic, the reported rate of having received the COVID-19 vaccine was found to be the same as U.S. citizens, a new UCLA Health study found.

Released: 22-Apr-2024 9:05 AM EDT
Rise seen in use of antibiotics for conditions they can’t treat – including COVID-19
Michigan Medicine - University of Michigan

America is going the wrong way when it comes to prescribing antibiotics, with 1 in 4 prescriptions going to patients who have conditions that the drugs won’t touch, a new study finds.

Newswise: From ashes to adversity: Lessons from South Australia's business recovery amidst bushfires and pandemic
Released: 15-Apr-2024 9:05 PM EDT
From ashes to adversity: Lessons from South Australia's business recovery amidst bushfires and pandemic
University of South Australia

New research has given insight into the resilience and recovery of businesses in two South Australian regions following a major bushfire event and disruptions caused by the COVID-19 pandemic.

10-Apr-2024 10:05 AM EDT
Researchers Find No Link Between COVID-19 Virus and Development of Asthma in Children
Children's Hospital of Philadelphia

In the wake of the COVID-19 pandemic, many families worried about the long-term effects posed by the SARS-COV-2 virus. Now, researchers found that a SARS-COV-2 infection likely does not increase the risk of asthma development in pediatric patients. The findings were published today in the journal Pediatrics.



close
2.62855